Synthesis of the nicotinamide coenzyme analogues (mNADHs, mNAD + s and tetrahydro-mNADHs)
The mNADHs (1) (2) (3) (4) (5) and mNAD + s (1-5)a were synthesised and characterised as previously described. 1 NMR data obtained corresponded to the previously reported characterisation. Once synthesised, the compounds were kept at -20 C for storage.
2.1. Reduction of mNADH nicotinamide biomimetics to 1,4,5,6 tetrahydro-mNADH derivatives (mNADH4s)
The aim was to generate a further reduced form of the reduced mNADHs (1) (2) (3) (4) (5) . The 1,4,5,6 tetrahydro-mNADHs (mNADH4 (1-5)b) were synthesised to bind in the active site of the ERs generating a "dead-end" complex which should be suitable for crystallisation and structural biochemical characterisation. The general structure of the tetrahydro-biomimetics is as follows: Pd catalyst on carbon (25 mg; extent of labelling 10% w w -1 loading matrix activated carbon support, Sigma Cat. 20, 569.9) was added into a Schlenk tube containing dried ethanol (6 mL). Then, biomimetic 1 (100 mg, 0.467 mmol) was added under inert atmosphere (no stirring). The solution became yellow.
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Finally, the Schlenk tube was evacuated and filled with hydrogen at atmospheric pressure. The reaction was run for approximately 20 h. A small aliquot of the reaction mixture was analysed by GC-MS as well as TLC. After removal of the Pd/C, the solution was colourless, indicating that all the starting material was reduced. The work-up was performed by filtering over celite and extensive washing with methanol. The clear solution was evaporated to afford a colourless oil (80 mg of crude product).
Judging from GC-MS analysis, the conversion into the desired reduced biomimetic 1b was 50% whereas the rest of the material were side-products generated by further reduction and/or cleavage of 1b.
Therefore, the reaction was repeated as previously described using biomimetic 1 (100 mg) and Pd/C (25 mg) in dried ethanol (6 mL). The reaction time was shortened to 2h and 30 min to determine whether a better chemoselectivity could be obtained. Reducing the reaction time led to the formation of higher amounts of the desired product 1b. The composition of the product mixture (determined by GC-MS) was:
82% of 1b, 13% of the fully reduced by-product (i.e. 1-benzylpiperidine-3-carboxamide) and 4% of cleaved derivatives.
The aliquots of the crude mixture from the first and the second reaction were combined and purified together by column chromatography on silica.
Conditions for column chromatography: GC-MS analysis showed that the "mono"-reduced desired product 2b was formed with 31% conversion.
The remaining was the "double"-reduced compound (i.e. 1-butylpiperidine-3-carboxamide).
The work-up was performed by filtering over celite and extensive washing with methanol. The clear solution was evaporated to afford a colourless crude oil that was purified by column chromatography.
Conditions for column chromatography: The crude mixture was purified by column chromatography on silica. GC-MS showed that the desired product 3b was formed with quantitative conversion (> 99%). Therefore, in this case, the hydrogenation was completely chemo-and regioselective, even when the reaction time was prolonged to 16 h.
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The work-up was performed by filtering over celite and extensive washing with methanol. The clear solution was evaporated to afford a red oil (150 mg, 0.697 mmol). The total yield was 99%. N N S14 1 H-NMR: 13 C-NMR: S16
GC-MS characterisation

Expression and purification of the ERs
All the enzymes used during this study were expressed and purified as described previously. [2] [3] [4] TsOYE was additionally purified by anion exchange chromatography using a HiPrepQ HP 16/10 column (GE Healthcare). The heat-shock purified protein was dissolved in start buffer (20 mM Tris/HCl, pH 8.0 buffer) and loaded onto the column. The elution of the protein was performed with a gradient between start buffer and elution buffer (20 mM Tris/HCl, 1M NaCl, pH 8.0 buffer).
All proteins were stored as concentrated stocks in 50 mM MOPS-NaOH, pH 7.0 buffer, supplemented with 5 mM CaCl2 at -20 °C.
Determination of the molar extinction coefficient for mNADHs (1-5)
24-32 mg of mNADHs (1-5) were dissolved in a certain amount of DMSO (600 µL for 1 and 2, 2.5 mL for 3 and 4 and 50 mL for 5) and filled up with buffer (50 mM MOPS-NaOH, pH 7.0, supplemented with 5 mM CaCl2) to 500 mL using a volumetric flask. Then, 4 dilutions were prepared by pipetting 5, 10, 20 and 40 mL in 100 mL volumetric flasks. UV-vis absorbance spectra were recorded and the absorbance of selected wavelengths was plotted against the concentration of the biomimetic-solution. The slope of the linear fit represents the molar extinction coefficient.
A summary of the calculated molar extinction coefficients can be found in Table S1 Table S1. Calculated extinction coefficients for mNADHs (1) (2) (3) (4) (5) Figure S1 shows the UV-vis absorbance spectra of the mNADHs (1-5).
Figure S1. UV-vis absorbance spectra of mNADHs (1-5) at 4 different concentrations. The insets represent the absorbance at the peak-maximum plotted against the biomimetic concentration for obtaining the molar extinction coefficient. S18
Reductive half-reaction
The reductive half-reactions between ERs, NAD(P)H and mNADHs were investigated using a High-Tech stopped-flow spectrophotometer (TgK Scientific Limited). The experiments were prepared and run under anaerobic conditions in N2-environment as previously described. All measurements were acquired in MOPS-NaOH buffer (50 mM, pH 7) supplemented with CaCl2 (5 mM The reductive half-reaction was modelled as shown in (1) (1)
where ER(ox) is the enzyme bound flavin in its oxidised state, [ER(ox)-NAD(P)H] is the enzyme-coenzyme complex and ER(red) is the enzyme bound flavin in its reduced state upon immediate NAD(P) + release after the reduction process. The dissociation constant KD is therefore determined according to equation (2):
(2) Figure S2 to Figure S5 show the hyperbolic fits for the reductive half-reaction of ERs with NAD(P)H and mNADHs. Table S2 summarises the reaction conditions for the assay. The following table shows the enantiomeric excess for the conversion of ketoisophorone 6 to levodione (R)-6a using 12 different ERs. The table with conversions can be found in the main paper ( Table 3 ).
Discussion of the results from biotransformations
The applicability of the mNAD biomimetics in organic synthesis as inexpensive alternatives to natural nicotinamide coenzymes was evaluated for the asymmetric reduction of an activated alkene as the test substrate. An extended panel of 12 ERs from the OYE family (PETNR, TOYE, OYE2, OYE3, XenA, XenB, LeOPR1, NerA, MR, TsOYE, DrOYE and RmOYE) was employed for the conversion of ketoisophorone 6 to levodione (R)-6a (see Table 3 , main paper).
The results of the screening showed that the biomimetics were overall well accepted, the only exception being biomimetic 5. This finding is in line with the kinetic parameters previously described in Table 1Error ! Reference source not found. and Table 2 (see main paper). The mNADH 5 stands out because it lacks the oxygen atom of the carbonyl moiety that may form a hydrogen bond with other residues within the enzyme pocket. Nevertheless, a conversion of 80% was still obtained with XenA suggesting that this ER might use a different binding mode for the coenzyme biomimetic.
The biomimetics 1-4 gave conversions up to >99%. Among the others, TsOYE, DrOYE and RmOYE afforded >99% conversion for the alkene reduction employing at least 2 biomimetics out of 5. We note that the conversions for alkene reduction catalysed by PETNR with biomimetic 3 (98%), TOYE with biomimetic 1 (90%), TsOYE with biomimetics 1-4 (>99%), DrOYE with biomimetic 1-4 (98 ->99%)
and RmOYE with biomimetic 1,4 (>99%) were equal or superseded the conversions for the same reactions using stoichiometric amounts of the natural coenzyme (i.e. 93% for PETNR, 56% for TOYE, >99% for TsOYE, 64% for DrOYE and 63% for RmOYE). In general, a minimum of 59% conversion was obtained with most of the ERs tested. The exceptions were the reductions catalysed by OYE2, OYE3
and MR, that generally afforded poor conversions (<42%) with all the mNADHs.
As expected, the source of hydride did not have a significant influence on the enantiomeric excess (Table S3 ) that is dependent on the intrinsic stereoselectivity of the enzyme. Besides, it is known from literature that the optical purity decreases over time due to spontaneous racemization that may account of the observed slight deviations in the ee values considering the synthetic biomimetics and the natural coenzymes. 5 
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mNAD + s recycling with the rhodium complex
So far, biocatalytic reactions with the biomimetics were carried out using stoichiometric amounts of coenzyme with respect to the substrate. Since mNAD + 1a is known to be reduced by the rhodium complex [Cp*Rh(bpy)(H2O)] 2+ , a recycling system was implemented in the reaction (Scheme S1).
Scheme S1. Investigated recycling system of mNADHs with TsOYE and the rhodium complex [Cp*Rh(bpy)(H2O)] 2+ . The nicotinamide coenzyme biomimetic mNAD + is reduced by [Cp*Rh(bpy)(H2O)] 2+ .
The rhodium complex [Cp*Rh(bpy)(H2O)] 2+ was synthesized as previously described. 6 Starting from previously optimized reaction conditions for a different system with the natural nicotinamide coenzyme, 7 the reduction of ketoisophorone 6 was performed with TsOYE, the oxidized biomimetic mNH2 + , the rhodium complex and sodium formate as a hydride source. Detailed procedure: in a 2 mL microcentrifuge plastic tube, MOPS buffer (50 mM, pH 7) supplemented with CaCl2 (5 mM) was degassed with nitrogen and ketoisophorone 6 (10 mM), NaHCO2 (60 mM), mNAD + (1a) (1 mM), TsOYE (3.3 µM), and [Cp*Rh(bpy)(H2O)] 2+ (250 µM) were consecutively added, to a final volume of 1 mL. The reactions were run at 50 °C, 800 rpm, for 4 h unless otherwise stated. Then, the product was extracted with EtOAc (2 × 500 µL), dried over MgSO4 and analysed by GC using a calibration curve, with 2 mM dodecane as an internal standard.
The full data set is reported in Table S4 . Applying the same reaction conditions, a conversion of more than 30% was obtained using NAD + and the biomimetic 1a (Table S4 , entry 2 and 3). The optical purity was the same (ee 85%). The reason of the imperfect optical purity might stem from a non-stereoselective chemical side reduction catalysed by the Rh complex (Table S4 , entry 6). However, a further optimisation of the reaction conditions led to 66% conversion with an enantiomeric excess of 85%. The following figures show the time course of the recycling system ( Figure S10, A) , the influence of varying the concentrations of the enzyme (Figure S10, B) , the oxidized coenzyme (Figure S10 , C) and the rhodium complex ( Figure S10, D) . All crystals were flash frozen by plunge freezing in liquid nitrogen (no additional cryo protection was required) prior to data collection at Diamond Light Source Ltd. S34
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Data Collection and Refinement
Individual data sets were collected from single cryo frozen crystals of XenA at Diamond Light Source. All data were scaled and processed using Xia2 8 and subsequently rebuilt and refined with iterative cycles of rebuilding and refinement carried out in COOT 9 and Phenix 10 . Validation with both MOLPROBITY 11 and PDB_REDO 12 was integrated into the iterative rebuild process. Complete data collection and refinement statistics can be found in Table S5 . 
Kinetic parameter for the conversion of cinnamaldehyde by NtDBR using NAD(P)H and mimics 1 and 3
Steady-state kinetic data for the conversion of cinnamaldehyde by NtDBR using NADPH as coenzyme were performed spectrophotometrically at 30 °C in KPi buffer (50 mM, pH 7.5) by following the NADPH oxidation at 365 nm (ε = 3256 M -1 cm -1 ). The reaction was started by the addition of varied concentrations of the substrate (50 µM to 1 mM, dissolved in DMSO as a 50 mM stock solution) to a constant concentration of NADPH (150 µM) and enzyme (3 µM); the initial rates were plotted against the substrate concentration. After fitting of the curve, a kapp value of 40 min -1 and a KM value of 91 µM could be obtained ( Figure S11 ).
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Figure S11. Steady-state kinetics for NtDBR with a fixed concentration of NADPH (150 µM) and varied concentrations of cinnamaldehyde.
The reaction rate for NtDBR with cinnamaldehyde and NADH, mNADH 1 and mNADH 3 were determined using biocatalytic reactions in KPi buffer (50 mM, pH 7.5). The reactions consisted of a constant amount of enzyme (10 µM) and coenzyme (6 mM) and various concentrations of substrate (1 to 5 mM) in 500 µL of total volume. The reactions were run at 30 °C, 800 rpm and, for each substrate concentration, the initial rate was determined by quenching the reactions at different time points. Then, the product was extracted with EtOAc (1 × 500 µL), dried over MgSO4 and analysed by GC as described before. For a comparison of the coenzymes the observed rates at 5 mM substrate concentrations are summarized in Table S7 Figure S12. Reaction rates for NtDBR with a fixed concentration of coenzyme (6 mM) and varied concentrations of cinnamaldehyde. YcnD was expressed and purified as described previously. 14 The activity for YcnD with NAD(P)H and biomimetics (1-5) was tested spectrophotometrically. First, the UV-vis absorbance spectrum of the coenzyme was recorded. Then, enzyme (final concentration 400 nM) was added and after an incubation time of 5 min the spectrum was recorded again. Immediately after the addition of the coenzyme, the solution containing the flavin-dependent enzyme became colourless, indicating the reduction of the flavin. Then, the flavin underwent slowly reoxidation by molecular oxygen. A bleach of the UV-vis absorbance spectra of the coenzyme showed activity for YcnD towards NAD(P)H and biomimetics 1, 2, 3 and 5 which can be seen in Figure S13 . Figure S13 . UV-vis absorbance spectra of YcnD (dotted line), reduced coenzymes (solid line) and coenzyme after incubation with YcnD for 5 min (dashed line).
